Medline Inc (MDLN) PT Lowered to $45 at Barclays, 'Material input costs are the biggest swing factor in F26'
Tweet Send to a Friend
Barclays analyst Glen Santangelo lowered the price target on Medline Inc (NASDAQ: MDLN) to $45.00 (from $50.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
